Eribulin mesylate induces bone mass loss by promoting osteoclastic bone resorption in mice
Over the past few decades, the clinical outcomes of patients with cancer have significantly improved mostly owing to the development of effective chemotherapeutic treatments. However, chronic health conditions such as bone mass loss and risk of fragility fractures caused by chemotherapy have also em...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2023-06-01
|
| coleção: | Bone Reports |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2352187223000414 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|